Eton Pharmaceuticals, Inc. is a pharmaceutical company. Co. is focused on developing and commercializing treatments for rare diseases. Co. has five commercial rare disease products: ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. Co. has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector. ALKINDI SPRINKLE is a granule hydrocortisone formulation designed to help provide accurate dosing for newborns and children with adrenal insufficiency. We show 27 historical shares outstanding datapoints in our coverage of ETON's shares outstanding history.
Understanding the changing numbers of ETON shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ETON versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ETON by allowing them to research ETON shares outstanding history
as well as any other stock in our coverage universe. |
Free ETON Email Alerts:
Video: Shares Outstanding Importance
